Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
Division of Surgical Oncology and Endocrine Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Cancer Cytopathol. 2019 Apr;127(4):231-239. doi: 10.1002/cncy.22104. Epub 2019 Feb 15.
The American Thyroid Association guidelines task force currently recommends definitive thyroidectomy or lobectomy after an indeterminate thyroid biopsy in children. This recommendation is based on evidence of a greater incidence and a higher risk of malignancy compared with adults in earlier pediatric studies. Such management may lead to overtreatment and unnecessary surgery for many children in the United States.
The objective of the current study was to re-evaluate pediatric thyroid nodules and assess the overall percentages and malignancy rates for indeterminate thyroid biopsies in children. In total, 302 pediatric thyroid fine-needle aspirations (FNAs) were analyzed retrospectively (2001-2018). Distribution percentages and malignancy rates were calculated for each category of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
Two indeterminate TBSRTC groups (atypia of undetermined significance/follicular lesion of undetermined significance and follicular neoplasm/suspicious for a follicular neoplasm) had much lower distribution percentages and malignancy rates compared with earlier pediatric series and American Thyroid Association guidelines. A meta-analysis further supported these findings and demonstrated distinctly different malignancy rates for the indeterminate groups (atypia of undetermined significance/follicular lesion of undetermined significance, follicular neoplasm/suspicious for a follicular neoplasm, and suspicious for malignancy), suggesting the need for TBSRTC category-specific management recommendations rather than a nondiscriminatory, up-front surgical approach.
Adult patients with indeterminate preoperative thyroid cytopathology are followed by repeat biopsy and possibly molecular testing before undergoing definitive surgery. However, in children, the guidelines are considerably more aggressive and recommend definitive surgery after the first indeterminate thyroid biopsy. Here, the largest pediatric cohort to date with meta-analysis is presented, and the authors propose a re-evaluation of this up-front approach to pediatric thyroid care.
目前,美国甲状腺协会指南工作组建议在儿童进行不确定甲状腺活检后行确定性甲状腺切除术或叶切除术。这一建议是基于早期儿科研究中与成人相比,儿童的发病率和恶性肿瘤风险更高的证据。这种治疗方法可能导致美国许多儿童过度治疗和不必要的手术。
本研究旨在重新评估儿科甲状腺结节,并评估不确定甲状腺活检的儿童总百分比和恶性肿瘤率。总共回顾性分析了 302 例儿科甲状腺细针抽吸活检(FNA)(2001-2018 年)。为每个 Bethesda 甲状腺细胞病理学报告系统(TBSRTC)类别计算分布百分比和恶性肿瘤率。
两个不确定的 TBSRTC 组(意义不明的不典型性/意义不明的滤泡性病变和滤泡性肿瘤/滤泡性肿瘤可疑)的分布百分比和恶性肿瘤率明显低于早期儿科系列和美国甲状腺协会指南。荟萃分析进一步支持了这些发现,并表明不确定组的恶性肿瘤率明显不同(意义不明的不典型性/意义不明的滤泡性病变、滤泡性肿瘤/滤泡性肿瘤可疑和可疑恶性),这表明需要根据 TBSRTC 类别制定具体的管理建议,而不是不分青红皂白地进行前期手术治疗。
术前甲状腺细胞学不确定的成年患者在接受确定性手术前,通过重复活检和可能的分子检测来进行随访。然而,在儿童中,指南更为激进,建议在第一次不确定的甲状腺活检后即行确定性手术。在此,报告了迄今为止最大的儿科队列和荟萃分析,作者建议重新评估这种针对儿科甲状腺护理的前期方法。